Effects of preanalytical variables on peptide and protein measurements in human serum and plasma: implications for clinical proteomics.
about
Guidelines for the standardization of preanalytic variables for blood-based biomarker studies in Alzheimer's disease researchProteomics in uveal melanoma research: opportunities and challenges in biomarker discoveryThe effect of pre-analytical variability on the measurement of MRM-MS-based mid- to high-abundance plasma protein biomarkers and a panel of cytokinesDegradation and Stabilization of Peptide Hormones in Human Blood SpecimensOptimizing sample handling for urinary proteomicsSaliva analysis by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF/MS): from sample collection to data analysis.Challenges for biomarker discovery in body fluids using SELDI-TOF-MS.Quality control based on isotopic distributions for high-throughput MALDI-TOF and MALDI-FTICR serum peptide profiling.Effect of storage temperature as a preanalytical variable on the lens crystallins protein quality for proteomic studies.Before you analyze a human specimen, think quality, variability, and bias.Impact of preanalytic factors on the design and application of integral biomarkers for directing patient therapyA proteomic approach to obesity and type 2 diabetes.Challenges in translating plasma proteomics from bench to bedside: update from the NHLBI Clinical Proteomics Programs.The role of ethylenediamine tetraacetic acid (EDTA) as in vitro anticoagulant for diagnostic purposes.Plasma/serum proteomics: pre-analytical issues.Pre-analytical stability of the plasma proteomes based on the storage temperature.Biomarkers in translational research: focus on discovery, development and translation of protein biomarkers to clinical immunoassays.Peptidomics analysis of human blood specimens for biomarker discovery.Analysis of human plasma proteins: a focus on sample collection and separation using free-flow electrophoresis.Cytokines as biomarkers in rheumatoid arthritis.Recent progress in selected reaction monitoring MS-driven plasma protein biomarker analysis.Pre-analytical and analytical variability in absolute quantitative MRM-based plasma proteomic studies.Differential expression of serum/plasma proteins in various infectious diseases: specific or nonspecific signatures.Mass spectrometry based biomarker discovery, verification, and validation--quality assurance and control of protein biomarker assays.Current status and advances in quantitative proteomic mass spectrometry.Direct Assessment of Plasma/Serum Sample Quality for Proteomics Biomarker Investigation.Advantages of multiplex proteomics in clinical immunology: the case of rheumatoid arthritis: novel IgXPLEX™: planar microarray diagnosis.Exploring phlebotomy technique as a pre-analytical factor in proteomic analyses by mass spectrometry.Pre-analytical effects of blood sampling and handling in quantitative immunoassays for rheumatoid arthritis.Analysis of factors influencing the generation of unqualified clinical samples and measures to prevent this generation.Ensuring sample quality for blood biomarker studies in clinical trials: a multicenter international study for plasma and serum sample preparation.Impact of Prolonged Blood Incubation and Extended Serum Storage at Room Temperature on the Human Serum Metabolome.Mining proteomic data for biomedical researchA feasibility study prior to an international multicentre paediatric study to assess pharmacokinetic/pharmacodynamic sampling and sample preparation procedures, logistics and bioanalysis
P2860
Q24289435-67E3150A-6F8B-4DA7-9386-789C19AB8165Q28297411-38895BBB-301D-4871-B9BA-0123DF5EC3E0Q28484137-F6EDEC9B-D620-45FA-8C55-0CDE0E828F96Q28546842-76EE7E6D-7F97-4FF3-80BD-68C8D3B08938Q30854221-7C583468-C2E5-4D7D-8CFF-5C07890EF6A9Q31136934-2A8DE1C8-9EEA-4401-940A-F187E9B5E771Q33520447-8FA864C6-542B-4EA2-A49F-C19EF656339BQ33602325-8B72C1C1-8B89-40BD-8F53-4FA318C0E38AQ33990546-60F19026-DD99-432B-8353-63963AD27EDBQ34462735-3863E500-C176-4B6B-8460-939E57AA9991Q35840045-CEF3F37C-9376-42A4-8BFD-5350A03D92A5Q35879468-8FAF7E17-865C-4C94-B647-EEB0B587D386Q36808058-583D1A68-FE6C-4A4D-A9B3-829F8B4D6FF4Q36813298-FBBEAB7A-C852-48DF-9664-90BF630BE24CQ36841871-19D46683-F7BB-40E5-B1F7-E7B8D92ADF52Q36858663-67CA4785-F049-457E-94BA-3732DB45F8C7Q36950431-E2EA4129-5DA8-40AE-87EA-188AD0AAF8C9Q36950443-AECB3C3A-4A4C-442D-8C0F-AFCE43DC8DE8Q37257661-A40421FA-AC91-4A9C-BA46-51C8DA63EAC4Q37661549-DB7323D4-C69E-4607-82DA-2F91D6791FA9Q37810186-983E9091-FCA2-43D8-892C-FD434F2C8484Q38164428-9A05AB5D-455E-48AB-9B56-5340EF4AF4C9Q38167708-6AFD2C64-5D42-4907-B82C-E12A51892CBAQ38203040-E70C59D8-F6D5-49B9-BD27-4D3770FAEADEQ39246192-9C971B4C-CA6C-41E4-8A63-741BABF0A004Q39413046-C44561DB-784B-4263-AB48-746C183984C4Q39920872-9F0466BC-2B08-4AC5-8EB5-57CE921D9766Q40411051-69BE9041-8B2A-4B98-AA35-28A9AE9604F1Q41773090-ECEA9EF6-3CCF-4BF6-A982-E83CDB2464A0Q42093327-2DDD6E1F-E335-4F70-8618-9E50613E2C38Q47097808-47A8D6F0-65EA-416B-9220-9E7BBEB6B1D0Q49996935-B6107CDC-70CA-41C4-B663-14835056A5D5Q56881273-9D93D4FF-95EA-4797-B748-2A8FD47B2730Q57100578-9A585BF6-5FCA-4D41-92C5-303C463B223E
P2860
Effects of preanalytical variables on peptide and protein measurements in human serum and plasma: implications for clinical proteomics.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Effects of preanalytical varia ...... tions for clinical proteomics.
@ast
Effects of preanalytical varia ...... tions for clinical proteomics.
@en
type
label
Effects of preanalytical varia ...... tions for clinical proteomics.
@ast
Effects of preanalytical varia ...... tions for clinical proteomics.
@en
prefLabel
Effects of preanalytical varia ...... tions for clinical proteomics.
@ast
Effects of preanalytical varia ...... tions for clinical proteomics.
@en
P2860
P356
P1476
Effects of preanalytical varia ...... tions for clinical proteomics.
@en
P2093
Alex J Rai
Frank Vitzthum
P2860
P304
P356
10.1586/14789450.3.4.409
P577
2006-08-01T00:00:00Z